X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA
- chromosome 5 -
| Symbol | GoldenPath (Mb) | Location | Description |
|---|---|---|---|
| PLEKHG4B | 193.373 | 5p15.33 | pleckstrin homology domain containing, family G (with RhoGef domain) member 4B |
| PDCD6 | 324.736 | 5pter-p15.2 | programmed cell death 6 |
| AHRR | 357.291 | 5p15.3 | aryl-hydrocarbon receptor repressor |
| EXOC3 | 496.334 | 5p15.33 | exocyst complex component 3 |
| SLC9A3 | 526.425 | 5p15.3 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 |
| TPPP | 712.977 | 5p15.3 | tubulin polymerization promoting protein |
| ZDHHC11 | 848.722 | 5p15.33 | zinc finger, DHHC-type containing 11 |
| NKD2 | 1062.168 | 5p15.3 | naked cuticle homolog 2 (Drosophila) |
| SLC12A7 | 1103.489 | 5p15 | solute carrier family 12 (potassium/chloride transporters), member 7 |
| TERT | 1306.287 | 5p15.33 | telomerase reverse transcriptase |
| CLPTM1L | 1371.000 | 5pter-p15.3 | CLPTM1-like |
| SLC6A3 | 1445.910 | 5p15.3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
| IRX2 | 2799.880 | 5p15.33 | iroquois homeobox 2 |
| ADAMTS16 | 5193.443 | 5p15 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 |
| NSUN2 | 6652.355 | 5p15.31 | NOL1/NOP2/Sun domain family, member 2 |
| SRD5A1 | 6686.500 | 5p15 | steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
| POLS | 6767.718 | 5p15 | polymerase (DNA directed) sigma |
| ADCY2 | 7449.343 | 5p15.3 | adenylate cyclase 2 (brain) |
| MTRR | 7922.217 | 5p15.3-p15.2 | 5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
| SEMA5A | 9088.138 | 5p15.2 | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
| CCT5 | 10303.282 | 5p15.2 | chaperonin containing TCP1, subunit 5 (epsilon) |
| ROPN1L | 10495.015 | 5p15.2 | ropporin 1-like |
| DAP | 10732.342 | 5p15.2 | death-associated protein |
| CTNND2 | 11024.952 | 5p15.2 | catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein) |
| TAG | 12627.968 | - | tumor antigen gene |
| TRIO | 14196.829 | 5p15.1-p14 | triple functional domain (PTPRF interacting) |
| ANKH | 14762.019 | 5p15.1 | ankylosis, progressive homolog (mouse) |
| FBXL7 | 15553.305 | 5p15.1 | F-box and leucine-rich repeat protein 7 |
| FAM134B | 16526.148 | 5p15.1 | family with sequence similarity 134, member B |
| CDH18 | 19508.914 | 5p15.2-p15.1 | cadherin 18, type 2 |
| CDH12 | 21786.911 | 5p14-p13 | cadherin 12, type 2 (N-cadherin 2) |
| CDH6 | 31229.553 | 5p15.1-p14 | cadherin 6, type 2, K-cadherin (fetal kidney) |
| RNASEN | 31436.359 | 5p13.3 | ribonuclease III, nuclear |
| PDZD2 | 31834.788 | 5p13.3 | PDZ domain containing 2 |
| MTMR12 | 32262.869 | 5p13.3 | myotubularin related protein 12 |
| ADAMTS12 | 33563.046 | 5q35 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 |
| SLC45A2 | 33980.478 | 5p13.3 | solute carrier family 45, member 2 |
| AMACR | 34023.663 | 5p13 | alpha-methylacyl-CoA racemase |
| C1QTNF3 | 34053.722 | - | C1q and tumor necrosis factor related protein 3 |
| RAD1 | 34941.125 | 5p13.2 | RAD1 homolog (S. pombe) |
| PRLR | 35099.985 | 5p14-p13 | prolactin receptor |
| SKP2 | 36187.946 | 5p13 | S-phase kinase-associated protein 2 (p45) |
| SLC1A3 | 36642.448 | 5p13 | solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
| NIPBL | 36912.742 | 5p13.2 | Nipped-B homolog (Drosophila) |
| GDNF | 37851.510 | 5p13.1-p12 | glial cell derived neurotrophic factor |
| LIFR | 38510.823 | 5p13-p12 | leukemia inhibitory factor receptor alpha |
| OSMR | 38881.893 | 5p13.1 | oncostatin M receptor |
| RICTOR | 38973.782 | 5p13.1 | rapamycin-insensitive companion of mTOR |
| DAB2 | 39407.537 | 5p13 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) |
| PTGER4 | 40715.789 | 5p13.1 | prostaglandin E receptor 4 (subtype EP4) |
| PRKAA1 | 40795.239 | 5p12 | protein kinase, AMP-activated, alpha 1 catalytic subunit |
| CARD6 | 40877.167 | 5p13.1 | caspase recruitment domain family, member 6 |
| C7 | 40945.356 | 5p13 | complement component 7 |
| PLCXD3 | 41342.806 | 5p13.1 | phosphatidylinositol-specific phospholipase C, X domain containing 3 |
| GHR | 42459.783 | 5p13-p12 | growth hormone receptor |
| SEPP1 | 42835.739 | 5q31 | selenoprotein P, plasma, 1 |
| MGC42105 | 43228.084 | 5p12 | hypothetical protein MGC42105 |
| FGF10 | 44340.854 | 5p13-p12 | fibroblast growth factor 10 |
| MRPS30 | 44844.784 | 5q11 | mitochondrial ribosomal protein S30 |
| HCN1 | 45295.110 | 5p12 | hyperpolarization activated cyclic nucleotide-gated potassium channel 1 |
| ITGA1 | 52119.893 | 5q11.2 | integrin, alpha 1 |
| ITGA2 | 52320.913 | 5q23-q31 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
| FST | 52812.352 | 5q11.2 | follistatin |
| HSPB3 | 53787.202 | 5q11.2 | heat shock 27kDa protein 3 |
| ESM1 | 54309.900 | 5q11.2 | endothelial cell-specific molecule 1 |
| CCNO | 54562.738 | 5p15.2-p13.1 | cyclin O |
| DHX29 | 54587.831 | 5q11.2 | DEAH (Asp-Glu-Ala-His) box polypeptide 29 |
| PPAP2A | 54756.442 | 5q11 | phosphatidic acid phosphatase type 2A |
| DDX4 | 55070.533 | 5p15.2-p13.1 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 |
| IL31RA | 55183.091 | 5q11.2 | interleukin 31 receptor A |
| IL6ST | 55272.452 | 5q11 | interleukin 6 signal transducer (gp130, oncostatin M receptor) |
| MAP3K1 | 56146.657 | 5q11.2 | mitogen-activated protein kinase kinase kinase 1 |
| PLK2 | 57785.569 | 5q12.1-q13.2 | polo-like kinase 2 (Drosophila) |
| RAB3C | 57914.696 | 5q13 | RAB3C, member RAS oncogene family |
| PDE4D | 58300.623 | 5q12 | phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila) |
| PART1 | 59819.515 | 5q12.1 | prostate androgen-regulated transcript 1 |
| ERCC8 | 60205.415 | 5q12.1 | excision repair cross-complementing rodent repair deficiency, complementation group 8 |
| NDUFAF2 | 60276.798 | 5q12.1 | NDUFA12-like |
| IPO11 | 61744.351 | 5q12.1 | importin 11 |
| SDCCAG10 | 64100.511 | 5q12.3 | serologically defined colon cancer antigen 10 |
| ADAMTS6 | 64480.320 | 5q12 | ADAM metallopeptidase with thrombospondin type 1 motif, 6 |
| ERBB2IP | 65258.140 | 5q12.3 | erbb2 interacting protein |
| MAST4 | 65927.932 | 5q12.3 | microtubule associated serine/threonine kinase family member 4 |
| CD180 | 66513.872 | 5q12 | CD180 molecule |
| PIK3R1 | 67558.218 | 5q13.1 | phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha) |
| CCNB1 | 68498.669 | 5q12 | cyclin B1 |
| CENPH | 68521.131 | 5p15.2 | centromere protein H |
| CDK7 | 68566.471 | 5q12.1 | cyclin-dependent kinase 7 |
| TAF9 | 68696.327 | 5q11.2-q13.1 | TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa |
| RAD17 | 68701.395 | 5q13 | RAD17 homolog (S. pombe) |
| OCLN | 68823.875 | 5q13.1 | occludin |
| NAIP | 70300.066 | 5q13.1 | NLR family, apoptosis inhibitory protein |
| GTF2H2 | 70366.709 | 5q12.2-q13.3 | general transcription factor IIH, polypeptide 2, 44kDa |
| MAP1B | 71438.874 | 5q13 | microtubule-associated protein 1B |
| TNPO1 | 72179.686 | 5q13.2 | transportin 1 |
| FOXD1 | 72777.843 | 5q12-q13 | forkhead box D1 |
| BTF3 | 72830.006 | 5q13.2 | basic transcription factor 3 |
| ENC1 | 73958.991 | 5q12-q13.3 | ectodermal-neural cortex (with BTB-like domain) |
| POLK | 74843.337 | 5q13 | polymerase (DNA directed) kappa |
| IQGAP2 | 75734.905 | 5q13.3 | IQ motif containing GTPase activating protein 2 |
| F2R | 76047.547 | 5q13 | coagulation factor II (thrombin) receptor |
| F2RL1 | 76150.610 | 5q13 | coagulation factor II (thrombin) receptor-like 1 |
| RAD21L1 | 76181.582 | - | RAD21-like 1 (S. pombe) |
| UBM2 | 76181.582 | 3p25.2-p25.1 | Melanoma, uveal, susceptibility to, 2 |
| UVM1 | 76181.582 | 3q24-q26 | Melanoma, uveal, susceptibility to, 1 |
| JMY | 78569.043 | 5q14.1 | junction-mediating and regulatory protein |
| THBS4 | 79366.747 | 5q13 | thrombospondin 4 |
| DHFR | 79957.801 | 5q11.2-q13.2 | dihydrofolate reductase |
| MSH3 | 79986.050 | 5q11-q12 | mutS homolog 3 (E. coli) |
| RASGRF2 | 80292.314 | 5q13 | Ras protein-specific guanine nucleotide-releasing factor 2 |
| CKMT2 | 80564.895 | 5q13.3 | creatine kinase, mitochondrial 2 (sarcomeric) |
| SSBP2 | 80751.429 | 5q14.1 | single-stranded DNA binding protein 2 |
| XRCC4 | 82409.073 | 5q13-q14 | X-ray repair complementing defective repair in Chinese hamster cells 4 |
| VCAN | 82803.339 | 5q14.3 | versican |
| EDIL3 | 83273.882 | 5q14 | EGF-like repeats and discoidin I-like domains 3 |
| RASA1 | 86600.522 | 5q13.3 | RAS p21 protein activator (GTPase activating protein) 1 |
| CCNH | 86725.839 | 5q13.3-q14 | cyclin H |
| MEF2C | 88051.922 | 5q14 | myocyte enhancer factor 2C |
| NR2F1 | 92944.799 | 5q14 | nuclear receptor subfamily 2, group F, member 1 |
| MAPK6PS1 | 95008.239 | 8q11.23 | mitogen-activated protein kinase 6 pseudogene 1 |
| MAPK6PS3 | 95008.239 | 13q14.13 | mitogen-activated protein kinase 6 pseudogene 3 |
| RHOBTB3 | 95092.606 | 5q15 | Rho-related BTB domain containing 3 |
| GLRX | 95175.431 | 5q14 | glutaredoxin (thioltransferase) |
| ELL2 | 95246.558 | 5q15 | elongation factor, RNA polymerase II, 2 |
| PCSK1 | 95751.875 | 5q15-q21 | proprotein convertase subtilisin/kexin type 1 |
| ERAP1 | 96122.271 | 5q15 | endoplasmic reticulum aminopeptidase 1 |
| ERAP2 | 96241.024 | 5q15 | endoplasmic reticulum aminopeptidase 2 |
| LNPEP | 96319.912 | 5q15 | leucyl/cystinyl aminopeptidase |
| RIOK2 | 96524.397 | 5q15 | RIO kinase 2 (yeast) |
| CHD1 | 98218.809 | 5q15-q21 | chromodomain helicase DNA binding protein 1 |
| ST8SIA4 | 100248.914 | 5q21 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
| PAM | 102229.426 | 5q14-q21 | peptidylglycine alpha-amidating monooxygenase |
| RAB9P1 | 104463.075 | 5q21.2 | RAB9, member RAS oncogene family, pseudogene 1 |
| EFNA5 | 106744.250 | 5q21 | ephrin-A5 |
| FER | 108111.422 | 5q21 | fer (fps/fes related) tyrosine kinase (phosphoprotein NCP94) |
| CAMK4 | 110587.981 | 5q21.3 | calcium/calmodulin-dependent protein kinase IV |
| STARD4 | 110861.921 | 5q22.1 | StAR-related lipid transfer (START) domain containing 4 |
| APC | 112101.483 | 5q21-q22 | adenomatous polyposis coli |
| ZRSR1 | 112255.207 | 5q22 | zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 1 |
| MCC | 112385.695 | 5q21 | mutated in colorectal cancers |
| TRIM36 | 114541.136 | 5q22.3 | tripartite motif-containing 36 |
| PGGT1B | 114575.476 | 5q22.3 | protein geranylgeranyltransferase type I, beta subunit |
| TNFAIP8 | 118719.495 | 5q23.1 | tumor necrosis factor, alpha-induced protein 8 |
| LOX | 121429.919 | 5q23.2 | lysyl oxidase |
| CSNK1G3 | 122875.692 | 5q23 | casein kinase 1, gamma 3 |
| ALDH7A1 | 125908.348 | 5q31 | aldehyde dehydrogenase 7 family, member A1 |
| SLC12A2 | 127447.382 | 5q23.3 | solute carrier family 12 (sodium/potassium/chloride transporters), member 2 |
| ADAMTS19 | 128824.002 | 5q31 | ADAM metallopeptidase with thrombospondin type 1 motif, 19 |
| CTGE1 | 129124.054 | 18q11.2 | cutaneous T-cell lymphoma-associated antigen 1 |
| RAPGEF6 | 130789.503 | 5q31.1 | Rap guanine nucleotide exchange factor (GEF) 6 |
| FNIP1 | 131005.306 | 5q23.3 | folliculin interacting protein 1 |
| ACSL6 | 131317.051 | 5q31 | acyl-CoA synthetase long-chain family member 6 |
| IL3 | 131424.246 | 5q31.1 | interleukin 3 (colony-stimulating factor, multiple) |
| CSF2 | 131437.384 | 5q31.1 | colony stimulating factor 2 (granulocyte-macrophage) |
| PDLIM4 | 131621.286 | 5q31.1 | PDZ and LIM domain 4 |
| IRF1 | 131846.684 | 5q31.1 | interferon regulatory factor 1 |
| IL5 | 131905.035 | 5q31.1 | interleukin 5 (colony-stimulating factor, eosinophil) |
| RAD50 | 131920.529 | 5q31 | RAD50 homolog (S. cerevisiae) |
| IL13 | 132021.764 | 5q31 | interleukin 13 |
| IL4 | 132037.272 | 5q31.1 | interleukin 4 |
| SEPT8 | 132119.596 | 5q31 | septin 8 |
| GDF9 | 132224.777 | 5q31.1 | growth differentiation factor 9 |
| AFF4 | 132238.971 | 5q31 | AF4/FMR2 family, member 4 |
| HMG1L10 | 132238.970 | 22q12.1 | high-mobility group (nonhistone chromosomal) protein 1-like 10 |
| HSPA4 | 132415.561 | 5q31.1-q31.2 | heat shock 70kDa protein 4 |
| TCF7 | 133479.215 | 5q31.1 | transcription factor 7 (T-cell specific, HMG-box) |
| SKP1 | 133520.468 | 5q31 | S-phase kinase-associated protein 1 |
| PPP2CA | 133560.048 | 5q31.1 | protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform |
| CDKL3 | 133671.592 | 5q31 | cyclin-dependent kinase-like 3 |
| UBE2B | 133734.769 | 5q23-q31 | ubiquitin-conjugating enzyme E2B (RAD6 homolog) |
| CAMLG | 134102.105 | 5q23 | calcium modulating ligand |
| DDX46 | 134122.360 | 5q31.1 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 46 |
| PITX1 | 134391.323 | 5q31 | paired-like homeodomain 1 |
| CXCL14 | 134934.275 | 5q31 | chemokine (C-X-C motif) ligand 14 |
| IL9 | 135255.834 | 5q31.1 | interleukin 9 |
| FBXL21 | 135300.162 | 5q31 | F-box and leucine-rich repeat protein 21 |
| TGFBI | 135392.597 | 5q31 | transforming growth factor, beta-induced, 68kDa |
| SMAD5 | 135496.435 | 5q31 | SMAD family member 5 |
| SPOCK1 | 136338.888 | 5q31 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
| WNT8A | 137447.673 | 5q31 | wingless-type MMTV integration site family, member 8A |
| KIF20A | 137543.248 | 5q31 | kinesin family member 20A |
| CDC23 | 137551.240 | 5q31 | cell division cycle 23 homolog (S. cerevisiae) |
| CDC25C | 137648.858 | 5q31 | cell division cycle 25 homolog C (S. pombe) |
| JMJD1B | 137716.184 | 5q31 | jumonji domain containing 1B |
| EGR1 | 137829.080 | 5q31.1 | early growth response 1 |
| ETF1 | 137869.687 | 5q31.1 | eukaryotic translation termination factor 1 |
| HSPA9 | 137918.923 | 5q31.1 | heat shock 70kDa protein 9 (mortalin) |
| CTNNA1 | 138117.006 | 5q31 | catenin (cadherin-associated protein), alpha 1, 102kDa |
| SLC23A1 | 138730.790 | 5q31.2-q31.3 | solute carrier family 23 (nucleobase transporters), member 1 |
| MYCL3 | 138730.793 | Xq27.2 | v-myc myelocytomatosis viral oncogene homolog 3 (avian) (pseudogene) |
| MGC29506 | 138751.157 | 5q23-q31 | hypothetical protein MGC29506 |
| DNAJC18 | 138775.280 | 5q31.2 | DnaJ (Hsp40) homolog, subfamily C, member 18 |
| UBE2D2 | 138920.935 | 5q31.2 | ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast) |
| NRG2 | 139207.444 | 5q23-q33 | neuregulin 2 |
| PURA | 139473.892 | 5q31 | purine-rich element binding protein A |
| HBEGF | 139692.613 | 5q23 | heparin-binding EGF-like growth factor |
| ANKHD1 | 139761.613 | 5q31.3 | ankyrin repeat and KH domain containing 1 |
| SRA1 | 139909.838 | 5q31.3 | steroid receptor RNA activator 1 |
| CD14 | 139991.501 | 5q22-q32|5q31.1 | CD14 molecule |
| DND1 | 140030.566 | 5q31.3 | dead end homolog 1 (zebrafish) |
| HARS | 140033.675 | 5q31.3 | histidyl-tRNA synthetase |
| TAF7 | 140678.242 | 5q31 | TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa |
| PCDHGA5 | 140724.082 | 5q31 | protocadherin gamma subfamily A, 5 |
| PCDHGC3 | 140835.753 | 5q31 | protocadherin gamma subfamily C, 3 |
| DIAPH1 | 140874.773 | 5q31 | diaphanous homolog 1 (Drosophila) |
| HDAC3 | 140980.627 | 5q31 | histone deacetylase 3 |
| LOC285634 | 140996.777 | 5p13.1 | similar to integrator complex subunit 6 isoform a |
| FCHSD1 | 140999.054 | 5q31.3 | FCH and double SH3 domains 1 |
| PCDH1 | 141212.867 | 5q32-q33 | protocadherin 1 |
| RNF14 | 141328.806 | 5q23.3-q31.1 | ring finger protein 14 |
| SPRY4 | 141670.192 | 5q31.3 | sprouty homolog 4 (Drosophila) |
| FGF1 | 141953.307 | 5q31 | fibroblast growth factor 1 (acidic) |
| ARHGAP26 | 142130.476 | 5q31 | Rho GTPase activating protein 26 |
| NR3C1 | 142637.689 | 5q31.3 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| HMHB1 | 143171.919 | 5q32 | histocompatibility (minor) HB-1 |
| YIPF5 | 143517.920 | 5q32 | Yip1 domain family, member 5 |
| POU4F3 | 145698.869 | 5q31 | POU class 4 homeobox 3 |
| PPP2R2B | 145949.261 | 5q31-q32 | protein phosphatase 2 (formerly 2A), regulatory subunit B, beta isoform |
| DPYSL3 | 146750.566 | 5q32 | dihydropyrimidinase-like 3 |
| SPINK1 | 147184.339 | 5q32 | serine peptidase inhibitor, Kazal type 1 |
| SPINK5 | 147423.759 | 5q32 | serine peptidase inhibitor, Kazal type 5 |
| HPC3 | 147529.489 | 20q13 | Prostate cancer, hereditary, 3 |
| HPC4 | 147529.489 | 7p11-q21 | Prostate cancer, hereditary, 4 |
| SPINK7 | 147672.183 | 5q33.1 | serine peptidase inhibitor, Kazal type 7 (putative) |
| FBXO38 | 147743.739 | 5q33.1 | F-box protein 38 |
| ADRB2 | 148186.349 | 5q31-q32 | adrenergic, beta-2-, receptor, surface |
| CSNK1A1 | 148855.038 | 5q32 | casein kinase 1, alpha 1 |
| PPARGC1B | 149090.057 | 5q33.1 | peroxisome proliferator-activated receptor gamma, coactivator 1 beta |
| SLC26A2 | 149320.493 | 5q31-q34 | solute carrier family 26 (sulfate transporter), member 2 |
| PDGFRB | 149473.595 | 5q31-q32 | platelet-derived growth factor receptor, beta polypeptide |
| CDX1 | 149526.537 | 5q31-q33 | caudal type homeobox 1 |
| CAMK2A | 149579.248 | 5q33.1 | calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha |
| CD74 | 149761.397 | 5q32 | CD74 molecule, major histocompatibility complex, class II invariant chain |
| GPX3 | 150380.192 | 5q23 | glutathione peroxidase 3 (plasma) |
| FAT2 | 150863.847 | 5q32-q33 | FAT tumor suppressor homolog 2 (Drosophila) |
| SPARC | 151021.207 | 5q31.3-q32 | secreted protein, acidic, cysteine-rich (osteonectin) |
| ATOX1 | 151102.577 | 5q32 | ATX1 antioxidant protein 1 homolog (yeast) |
| G3BP1 | 151131.669 | 5q33.1 | GTPase activating protein (SH3 domain) binding protein 1 |
| SAP30L | 153805.776 | 5q33.2 | SAP30-like |
| CNOT8 | 154218.391 | 5q31-q33 | CCR4-NOT transcription complex, subunit 8 |
| GEMIN5 | 154247.169 | 5q33.2 | gem (nuclear organelle) associated protein 5 |
| HAVCR1 | 156389.109 | 5q33.2 | hepatitis A virus cellular receptor 1 |
| HAVCR2 | 156445.421 | 5q33.3 | hepatitis A virus cellular receptor 2 |
| ITK | 156540.485 | 5q31-q32 | IL2-inducible T-cell kinase |
| ADAM19 | 156836.891 | 5q32-q33 | ADAM metallopeptidase domain 19 (meltrin beta) |
| IL12B | 158674.369 | 5q31.1-q33.1 | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
| ADRA1B | 159276.318 | 5q23-q32 | adrenergic, alpha-1B-, receptor |
| FABP6 | 159589.015 | 5q33.3-q34 | fatty acid binding protein 6, ileal (gastrotropin) |
| C1QTNF2 | 159707.365 | 5q33.3 | C1q and tumor necrosis factor related protein 2 |
| PTTG1 | 159781.443 | 5q35.1 | pituitary tumor-transforming 1 |
| CCNG1 | 162797.155 | 5q32-q34 | cyclin G1 |
| HMMR | 162820.241 | 5q33.2-qter | hyaluronan-mediated motility receptor (RHAMM) |
| MAT2B | 162862.809 | 5q34-q35 | methionine adenosyltransferase II, beta |
| WWC1 | 167651.670 | 5q35.1 | WW and C2 domain containing 1 |
| PPP1R3G | 167975.935 | 6p25.1 | protein phosphatase 1, regulatory (inhibitor) subunit 3G |
| DOCK2 | 168996.871 | 5q35.1 | dedicator of cytokinesis 2 |
| FOXI1 | 169465.495 | 5q34 | forkhead box I1 |
| LCP2 | 169607.667 | 5q33.1-qter | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
| KCNMB1 | 169737.745 | 5q34 | potassium large conductance calcium-activated channel, subfamily M, beta member 1 |
| GABRP | 170143.343 | 5q33-q34 | gamma-aminobutyric acid (GABA) A receptor, pi |
| RANBP17 | 170221.600 | 5q34 | RAN binding protein 17 |
| TLX3 | 170668.893 | 5q35.1 | T-cell leukemia homeobox 3 |
| NPM1 | 170747.403 | 5q35 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
| FGF18 | 170779.272 | 5q34 | fibroblast growth factor 18 |
| STK10 | 171401.679 | 5q35.1 | serine/threonine kinase 10 |
| DUSP1 | 172127.707 | 5q34 | dual specificity phosphatase 1 |
| BNIP1 | 172504.051 | 5q33-q34 | BCL2/adenovirus E1B 19kDa interacting protein 1 |
| NKX2-5 | 172591.744 | 5q34 | NK2 transcription factor related, locus 5 (Drosophila) |
| STC2 | 172674.332 | 5q35.2 | stanniocalcin 2 |
| MSX2 | 174084.181 | 5q34-q35 | msh homeobox 2 |
| HRH2 | 175042.318 | 5q35.2 | histamine receptor H2 |
| NEWENTRY | 175748.379 | - | Record to support submission of GeneRIFs for a gene not in Entrez Gene (human; man). |
| CLTB | 175752.063 | 4q2-q3|5q35 | clathrin, light chain (Lcb) |
| RNF44 | 175886.306 | 5q35.2 | ring finger protein 44 |
| PCDH24 | 175908.971 | - | - |
| UNC5A | 176170.166 | 5q35.2 | unc-5 homolog A (C. elegans) |
| HK3 | 176240.477 | 5q35.2 | hexokinase 3 (white cell) |
| UIMC1 | 176264.612 | 5q35.2 | ubiquitin interaction motif containing 1 |
| FGFR4 | 176449.157 | 5q35.1-qter | fibroblast growth factor receptor 4 |
| NSD1 | 176494.691 | 5q35.2-q35.3 | nuclear receptor binding SET domain protein 1 |
| RAB24 | 176660.806 | 5q35.3 | RAB24, member RAS oncogene family |
| TRESMCR | 176663.406 | 17p11.2 | TRE oncogene, Smith Magenis syndrome chromosome region |
| RGS14 | 176717.450 | 5q35.3 | regulator of G-protein signaling 14 |
| GRK6 | 176786.293 | 5q35 | G protein-coupled receptor kinase 6 |
| PDLIM7 | 176843.001 | 5q35.3 | PDZ and LIM domain 7 (enigma) |
| DDX41 | 176871.185 | 5q35.3 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 |
| B4GALT7 | 176959.778 | 5q35.2-q35.3 | xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I) |
| PROP1 | 177351.842 | 5q35.3 | PROP paired-like homeobox 1 |
| NOLA2 | 177509.074 | 5q35.3 | nucleolar protein family A, member 2 (H/ACA small nucleolar RNPs) |
| CLK4 | 177962.272 | 5q35 | CDC-like kinase 4 |
| ADAMTS2 | 178510.737 | 5qter | ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
| CANX | 179058.536 | 5q35 | calnexin |
| MAML1 | 179092.457 | 5q35 | mastermind-like 1 (Drosophila) |
| LTC4S | 179153.592 | 5q35 | leukotriene C4 synthase |
| MGAT4B | 179156.711 | 5q35 | mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B |
| SQSTM1 | 179180.503 | 5q35 | sequestosome 1 |
| RNF130 | 179315.080 | 5q35.3 | ring finger protein 130 |
| RASGEF1C | 179460.402 | 5q35.3 | RasGEF domain family, member 1C |
| MAPK9 | 179595.390 | 5q35 | mitogen-activated protein kinase 9 |
| SCGB3A1 | 179949.711 | 5q35-qter | secretoglobin, family 3A, member 1 |
| FLT4 | 179961.113 | 5q35.3 | fms-related tyrosine kinase 4 |